RT Book, Section
A1 Fitzpatrick, Meghan E.
A1 Prendergast, Niall T.
A1 Rivera-Lebron, Belinda
A2 Papadakis, Maxine A.
A2 McPhee, Stephen J.
A2 Rabow, Michael W.
A2 McQuaid, Kenneth R.
SR Print(0)
ID 1186012744
T1 Pneumonia
T2 Current Medical Diagnosis & Treatment 2022
YR 2022
FD 2022
PB McGraw-Hill Education
PP New York, NY
SN 9781264269389
LK accessmedicine.mhmedical.com/content.aspx?aid=1186012744
RD 2023/10/03
AB KEY  CLINICAL  UPDATES  IN  PNEUMONIAProcalcitonin  is  not  recommended  as  a  “rule-out”  test  for  bacterial  pneumonia;  studies  have  not  found  a  threshold  at  which  bacterial  pneumonia  can  be  reliably  distinguished  from  viral  pneumonia  based  on  procalcitonin  levels.Empiric  antibacterial  agents  are  recommended  regardless  of  procalcitonin  level  at  time  of  presentation.Based  on  limited  data  and  because  of  the  potential  for  complications  (eg,  hyperglycemia),  the  IDSA/ATS  guidelines  recommend  against  corticosteroids  in  the  treatment  CAP  of  any  severity.Corticosteroids  are  recommended  for  patients  with  CAP  who  may  also  have  severe  septic  shock,  acute  exacerbation  of  asthma  or  COPD,  or  adrenal  insufficiency.